Memory B cells: A proposed new immunological correlate for protective efficacy of Japanese encephalitis vaccine

Expert Review of Vaccines

Volumn 12, Issue 8, 2013, Pages 871-873

  Konishi, Eiji ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

adjuvant; immunological correlate; Japanese encephalitis virus; knockout mouse; memory B cells; mouse model; neutralizing antibodies; vaccine

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; JAPANESE ENCEPHALITIS; MEMORY CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ENCEPHALITIS, JAPANESE; INULIN; JAPANESE ENCEPHALITIS VACCINES;

EID: 84887805523     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2013.814828     Document Type: Article

References (11)

1. Gubler DJ, Kuno G, Markoff L. Flaviviruses. In: Fields Virology (5th Edition). Knipe DM, Howley PM (Eds). Lippincott- Raven, PA, USA, 1153-1252 (2007
2. Halstead SB, Jacobsen J. Japanese encephalitis vaccines. In: Vaccines (5th Edition). Plotkin SA, Orenstein WA, Offit PA (Eds). Saunders, Elsevier, MO, USA 311-352 (2008
3. Feroldi E, Capeding MR, Boaz M, Gailhardou S, Meric C, Bouckenooghe A. Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children. Hum. Vaccin. Immunother. 9(4), PMID 23442823 (2013
4. Halstead SB, Thomas SJ. New Japanese encephalitis vaccines: Alternatives to production in mouse brain. Expert Rev. Vaccines 10(3), 355-364 (2011
5. Ishikawa T, Konishi E. Combating Japanese encephalitis: Vero-cell derived inactivated vaccines and the situation in Japan. Future Virol. 5(6), 785-799 (2010
6. Hombach J, Solomon T, Kurane I, Jacobson J, Wood D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004. Vaccine 23(45), 5205-5211 (2005
7. Larena M, Prow NA, Hall RA, Petrovsky N, Lobigs M. JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody. J. Virol. 87(8), 4395-4402 (2013
8. Lobigs M, Pavy M, Hall RA et al. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses. J. Gen. Virol. 91(Pt 6), 1407-1417 (2010
9. Desai K, Coudeville L, Bailleux F. Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine. Vaccine 30(15), 2510-2515 (2012
10. Larena M, Regner M, Lobigs M. Cytolytic effector pathways and IFN-? help protect against Japanese encephalitis. Eur. J. Immunol. 43(7), 1789-1798 (2013
11. Honda-Okubo Y, Saade F, Petrovsky N. Advax, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses. Vaccine 30(36), 5373-5381 (2012).Menducidi testrum